
Rakibul Islam, PhD
Senior Research Fellow
Dr.
Rakibul Islam is a clinical epidemiologist with a specific interest in
non-communicable diseases in women, and currently working at the Women's
Health Research Program, Monash University, Australia. His current projects address
sex hormones and their impact on cardiovascular disease risk as well as on
cancer, cognition and frailty in older Australian women that has attractive
possibilities for pharmacological interventions aimed at prolonging the
morbidity-free life span of older women. He is a lead researcher in a large
study of the physical and psychological health of young Australian women. Currently,
he is also working on a couple of projects on African and Middle Eastern
refugees in Australian and Rohingya refugees in Bangladesh.
Dr.
Islam is a highly experienced women's health epidemiologist with over 80
publications in reputed journals, including the Lancet, the Lancet Diab &
Endo, BMJ, JAMA, JCEM. Dr. Islam was an invited speaker in the full-day
workshop in Berlin, Germany to develop the first “global consensus position
statement on the use of testosterone therapy for women.” His role was to ensure
all the leading clinicians from 11 international societies understood the major
meta-analysis that he undertook. Hence, he was awarded the Australasian
Menopause Society Scientific Prize in 2020, which is highly prestigious.
He earned his PhD from the School of Public Health and Preventive Medicine, Monash University, Australia. He completed his first year of post-doctoral fellowship at the Baker Heart and Diabetes Institute, Australia in collaboration with CDC, USA. Dr. Islam has over 10 years of teaching experience in Bangladesh and in Australia. He currently teaches introductory epidemiology and introductory biostatistics for BioMed Honours students at the Monash University, Australia.